Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering
-
Runway Growth Finance Corp. Prices Offering of 7.50% Notes due 2027
-
Runway Growth Finance Corp. Prices Offering of 7.50% Notes due 2027
-
Runway Growth Finance Corp. Commences Offering of Notes
-
Runway Growth Finance Corp. Commences Offering of Notes
-
UPDATE: Ladenburg Thalmann Downgrades Invitae Corporation (NVTA) to Neutral
-
Trinity Capital Inc. Prices Reopening of $50.0 Million of 7.00% Notes due 2025
-
745 Capital Announces Extension of Cash Tender Offer for Ladenburg Thalmann Financial Services Inc. 6.50% Senior Notes Due 2027 through August 12, 2022 at $15.00 plus Accrued Interest, NYSE symbol LTS
-
Kevin DeGeeter Joins Nabsys as Chief Financial Officer
-
UPDATE: Rhythm Pharmaceuticals (RYTM) PT Raised to $23 at Ladenburg Thalmann; 'H.O. Data Is Imcivree’s Best Yet, With Biggest Market Opportunity'
-
Saratoga Investment Corp. Announces Fiscal First Quarter 2023 Financial Results
-
Advisor Group Continues Strategic Growth with Acquisition of American Portfolios Financial Services, Inc.
-
Athenex (ATNX) Sells Revenues from U.S. and European Royalty and Milestone Interests in Klisyri to Sagard Healthcare Partners and Oaktree for $80M
-
Athenex Announces Sale of Revenues from U.S. and European Royalty and Milestone Interests in Klisyri® (tirbanibulin) to Sagard Healthcare Partners and Oaktree
-
Athenex Announces Sale of Revenues from U.S. and European Royalty and Milestone Interests in Klisyri® (tirbanibulin) to Sagard Healthcare Partners and Oaktree
-
745 Capital Commences Tender Offer for Senior Notes
-
GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse
-
745 Capital Commences Tender Offer for Senior Notes
-
Oxford Lane (OXLC) Prices Preferred Stock Offering
-
Oxford Lane Capital Corp. Prices Preferred Stock Offering
-
Oxford Lane (OXLC) Announces Preferred Stock Offering
-
Oxford Lane Capital Corp. Announces Preferred Stock Offering
-
Great Elm Group, Inc. Prices Public Offering of $25,000,000 of 7.25% Notes Due 2027
-
Great Elm Group Announces Public Offering of Unsecured Notes
-
Sachem Capital Corp. Announces Sale of an Additional $2.5 Million of 7.125% Notes from Exercise of Over Allotment Option
-
Advisor Group Welcomes IronBridge Wealth Counsel To Its Network
-
Top Penny Stocks Today: What's Moving AVDL, BKSY, NILE, INO, & ALLR
-
Metal Sky Star Acquisition Corporation Announces the Separate Trading of its Ordinary Shares, Rights and Warrants
-
Advisor Group Accelerates Growth and Expands Multi-Channel Leadership with Acquisition of Infinex Financial Holdings, with over $30 Billion in Assets
-
Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
-
Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
-
Vallon Pharmaceuticals Inc. (VLON) Prices 3.7M Share Offering at $1.06/sh
-
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
-
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
-
TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
-
Sachem Capital Corp. Announces Closing of Public Offering of $27.5 Million of 7.125% Notes
-
Saratoga Investment Corp. Announces Exercise and Closing of Underwriters’ Option to Purchase Additional 6.00% Notes Due 2027
-
Saratoga Investment Corp. Announces Exercise and Closing of Underwriters’ Option to Purchase Additional 6.00% Notes Due 2027
-
Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
-
Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
-
Advisor Group Continues To Grow and Build On Its Strategic Vision With Addition Of Experienced Business Strategist and Compliance Expert
-
Sachem Capital Corp. (SACH) Prices $27.5M Notes Offering
-
Sachem Capital Corp. Prices Registered Public Offering of $27.5 Million of 7.125% Notes
-
Palisade Bio Inc. (PALI) Announces 3.65M Share Direct Offering at $0.55/sh
-
Palisade Bio Announces $2.0 Million Registered Direct Offering
-
Arca Biopharma (ABIO) Retains Ladenburg Thalmann to Support Strategic Options Review
-
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
-
Advisor Group Selects CAIS for Alternative Investment Access and Education
-
Sachem Capital Corp. (SACH) Announces Registered Public Offering of Notes
-
Sachem Capital Corp. Announces Registered Public Offering of Notes

